Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Infosys Stock (INFY)
Track Infosys stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
INFY
Infosys
technology
At close
$10.76
▼ -0.28 (-2.54%)
Oct 5, 4:00 PM ET
After-hours
$10.76
• +0.00 (0.00%)
Oct 5, 4:10 PM ET
Market Cap
$43.66B
P/E Ratio
14.0x
1Y Return
-29.50%
EPS (TTM)
$0.82
Read the latest TheStreet Pro articles mentioning Infosys, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
8 articlesDaily Diary Mentions
1 mentionUpside, Downside Movers in the Morning